Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations
Catherine A. Koss(University of California, San Francisco), Monica Gandhi(University of California, San Francisco), Stephanie Van Horn(Family Health International 360), Kailazarid Gomez Feliciano(Family Health International 360), Sharon L. Hillier(Magee-Womens Research Institute), David V. Glidden(University of California, San Francisco), Robert M. Grant(Georgetown University), Howard Horng(University of California, San Francisco), Jeanne Marrazzo(St. Vincent's Birmingham), Zvavahera M. Chirenje(Global Brain Health Institute), Albert Liu(San Francisco Department of Public Health), Peter Bacchetti(University of California, San Francisco), Edward Livant(University of Pittsburgh), Ariane van der Straten(University of California, San Francisco), Leslie Z. Benet(University of California, San Francisco), Brenda Gati Mirembe(MUJHU Research Collaboration), Alexander Louie(University of California, San Francisco), Nyaradzo Mgodi(University of Zimbabwe)
Cited by 57
Related Papers
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
|New England Journal of Medicine|2015|1.3k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Abnormal Brain Development in Newborns with Congenital Heart Disease
|New England Journal of Medicine|2007|851
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768